Elise S. Eerenberg

2.2k total citations · 1 hit paper
17 papers, 1.5k citations indexed

About

Elise S. Eerenberg is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Elise S. Eerenberg has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 13 papers in Internal Medicine and 6 papers in Hematology. Recurrent topics in Elise S. Eerenberg's work include Venous Thromboembolism Diagnosis and Management (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Elise S. Eerenberg is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (13 papers), Atrial Fibrillation Management and Outcomes (12 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Elise S. Eerenberg collaborates with scholars based in Netherlands, United States and United Kingdom. Elise S. Eerenberg's co-authors include Marcel Levi, Pieter W. Kamphuisen, Joost C.M. Meijers, Meertien K. Sijpkens, Harry R. Büller, Paul F. Teunissen, Matthijs Jansen, Niels van Royen, Maurits R. Hollander and Harry R. Büller and has published in prestigious journals such as Circulation, Blood and European Heart Journal.

In The Last Decade

Elise S. Eerenberg

17 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

2011 997 citations Elise S. Eerenberg, Pieter W. Kamphuisen et al. Circulation profile →

Peers

Countries citing papers authored by Elise S. Eerenberg

Since Specialization

Citations

This map shows the geographic impact of Elise S. Eerenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elise S. Eerenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elise S. Eerenberg more than expected).

Fields of papers citing papers by Elise S. Eerenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elise S. Eerenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elise S. Eerenberg. The network helps show where Elise S. Eerenberg may publish in the future.

Co-authorship network of co-authors of Elise S. Eerenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Elise S. Eerenberg. A scholar is included among the top collaborators of Elise S. Eerenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elise S. Eerenberg. Elise S. Eerenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients 2018 ·Thrombosis and Haemostasis ·Noémie Kraaijpoel, Nick van Es, Suzanne M. Bleker, Marjolein Brekelmans, Elise S. Eerenberg, Saskia Middeldorp, Alexander T. Cohen, Gary E. Raskob, Harry R. Büller	6
2	Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists 2017 ·Thrombosis and Haemostasis ·Elise S. Eerenberg, Alexander T. Cohen, Saskia Middeldorp, Gary E. Raskob, (unknown), (unknown), Marjolein Brekelmans	26
3	The role of ADAMTS13 in acute myocardial infarction: cause or consequence? 2016 ·Cardiovascular Research ·Elise S. Eerenberg, Paul F. Teunissen, Bert‐Jan H. van den Born, Joost C.M. Meijers, Maurits R. Hollander, Matthijs Jansen, R. Tijssen, Jeroen A.M. Beliën, Peter M. van de Ven, M. F. A. Aly, Otto Kamp, Hans W.M. Niessen, Pieter W. Kamphuisen, Marcel Levi, Niels van Royen	19
4	Changes in Coronary Blood Flow After Acute Myocardial Infarction 2016 ·JACC: Cardiovascular Interventions ·Guus A. de Waard, Maurits R. Hollander, Paul F. Teunissen, Matthijs Jansen, Elise S. Eerenberg, Aernout M. Beek, Koen Marques, Peter M. van de Ven, Ingrid M. Garrelds, A.H. Jan Danser, Dirk J. Duncker, Niels van Royen	42
5	Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients 2016 ·Blood ·Noémie Kraaijpoel, Nick van Es, Suzanne M. Bleker, Marjolein Brekelmans, Elise S. Eerenberg, Saskia Middeldorp, Alexander T. Cohen, Harry R. Büller	1
6	Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists 2015 ·Journal of Thrombosis and Haemostasis ·Elise S. Eerenberg, Saskia Middeldorp, Marcel Levi, Anthonie W.A. Lensing, Harry R. Büller	38
7	Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage 2013 ·European Heart Journal ·Lourens Robbers, Elise S. Eerenberg, Paul F. Teunissen, Matthijs Jansen, Maurits R. Hollander, Anton J.G. Horrevoets, Paul Knaapen, Robin Nijveldt, Martijn W. Heymans, Marcel Levi, Albert C. van Rossum, Hans W.M. Niessen, C Marcu, Aernout M. Beek, Niels van Royen	154
8	The Potential Therapeutic Benefit of Targeting ADAMTS13 Activity 2013 ·Seminars in Thrombosis and Hemostasis ·Marcel Levi, Elise S. Eerenberg	12
9	Response to Letters Regarding Article, “Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects” 2012 ·Circulation ·Elise S. Eerenberg, Meertien K. Sijpkens, Joost C.M. Meijers, Harry R. Büller, Marcel Levi, Pieter W. Kamphuisen	3
10	Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate breakdown → 2011 ·Circulation ·Elise S. Eerenberg, Pieter W. Kamphuisen, Meertien K. Sijpkens, Joost C.M. Meijers, Harry R. Büller, Marcel Levi	997
11	Anticoagulants 2011 ·Hämostaseologie ·Elise S. Eerenberg, (unknown), Marcel Levi	10
12	Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents 2011 ·Journal of Thrombosis and Haemostasis ·Marcel Levi, Elise S. Eerenberg, Pieter W. Kamphuisen	113
13	New anticoagulants: Moving on from scientific results to clinical implementation 2011 ·Annals of Medicine ·Elise S. Eerenberg, Josien van Es, Meertien K. Sijpkens, Harry R. Büller, Pieter W. Kamphuisen	4
14	How to prevent, treat, and overcome current clinical challenges of VTE 2011 ·Journal of Thrombosis and Haemostasis ·Johan H. van Es, Elise S. Eerenberg, Pieter W. Kamphuisen, Harry R. Büller	18
15	Periprocedural reversal and bridging of anticoagulant treatment. 2011 ·PubMed ·Marcel Levi, Elise S. Eerenberg, Pieter W. Kamphuisen	9
16	Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. 2010 ·PubMed ·Marcel Levi, Elise S. Eerenberg, Ester Löwenberg, Pieter W. Kamphuisen	40
17	Prothrombin Complex Concentrate Reverses the Anticoagulant Effect of Rivaroxaban In Healthy Volunteers. 2010 ·Blood ·Elise S. Eerenberg, Meertien K. Sijpkens, Pieter W. Kamphuisen, Joost C.M. Meijers, Marcel Levi	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact